Comparison of serum markers in first-trimester down syndrome screening.

Maternal hormones during early pregnancy: a cross-sectional study. Cancer Causes Control (2010) 0.82

First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption. Obstet Gynecol (2017) 0.75

Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol (2007) 0.75

A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med (2011) 6.11

Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol (2006) 5.99

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med (2009) 5.69

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med (2011) 4.98

First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med (2005) 4.89

Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol (2012) 4.63

Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. Am J Obstet Gynecol (2004) 4.10

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med (2003) 4.04

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med (2004) 3.32

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med (2012) 3.18

The National Children's Study: a 21-year prospective study of 100,000 American children. Pediatrics (2006) 3.16

Effectiveness of electronic fetal monitoring with additional ST analysis in vertex singleton pregnancies at >36 weeks of gestation: an individual participant data metaanalysis. Am J Obstet Gynecol (2013) 3.10

Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn (2013) 2.87

A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis. N Engl J Med (2015) 2.86

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med (2010) 2.81

Assisted reproductive technology and pregnancy outcome. Obstet Gynecol (2005) 2.77

A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol (2007) 2.73

Evaluation of third-degree and fourth-degree laceration rates as quality indicators. Obstet Gynecol (2015) 2.64

Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60

Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol (2008) 2.52

Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med (2013) 2.48

Responses by pregnant Jehovah's Witnesses on health care proxies. Obstet Gynecol (2004) 2.45

First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40

Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol (2013) 2.33

First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol (2007) 2.31

Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta (2007) 2.31

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. Am J Obstet Gynecol (2012) 2.24

Intrapartum management of category II fetal heart rate tracings: towards standardization of care. Am J Obstet Gynecol (2013) 2.10

Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med (2014) 2.07

First-trimester sonographic screening for Down syndrome. Obstet Gynecol (2003) 2.05

Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging workshop. Obstet Gynecol (2014) 2.05

Antiphospholipid antibodies in stillbirth. Obstet Gynecol (2013) 2.04

Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α-hydroxyprogesterone caproate). Obstet Gynecol (2011) 2.01

First-trimester cystic hygroma: relationship of nuchal translucency thickness and outcomes. Obstet Gynecol (2012) 2.00

Standards and guidelines for CFTR mutation testing. Genet Med (2002) 1.94

Choroid plexus cyst and echogenic intracardiac focus in women at low risk for chromosomal anomalies. J Ultrasound Med (2004) 1.94